Imagine if checking your gut health was as fast as a blood test instead of waiting days for a lab. This technology uses a special imaging method to 'see' DNA patterns quickly without the slow process of traditional sequencing. It turns a complex biological puzzle into a fast digital map of your microbiome.
Current microbiome analytics are too slow, expensive, and inaccurate for real-time medical use. This prevents doctors from tracking disease states and therapies effectively for personalized medicine.
A functional microbiome DNA analyzer prototype with automated sample handling and associated chemoenzymatic consumables.
If you are a drug discovery firm dealing with slow patient response tracking during clinical trials — this project developed a microbiome analyzer that provides results in hours. This allows for faster correlations between microbiome changes and therapy success.
If you are a diagnostic clinic dealing with expensive and inaccurate microbiome tests for diabetes or cancer — this project developed a high-throughput profiling device. It enables personalized medicine by tracking disease states in real-time.
If you are a research lab dealing with the high cost of DNA sequencing players — this project developed a custom analysis device and consumables. It allows for the analysis of multiple microbiomes in a single run to accelerate research pipelines.
Based on available project data, specific pricing is not listed, but the objective is to replace methods that are currently too slow and expensive.
Yes, the project aims for a capacity of 300k profiles per year analyzed in-house to target a 2.5B market.
The technology is based on DNA imaging techniques invented in the lab of the co-founders; however, specific licensing terms are not provided in the report.
The technology enables high quality microbiome analysis to be available to patients and researchers within the timeframe of hours.
The device includes bespoke remote monitoring to support global placement and servicing.
The project is led by a single Belgian SME, Perseus Biomics, which acted as the sole partner. This 100% industry-led structure indicates a strong focus on commercialization and rapid prototyping rather than academic research, utilizing a lean approach to reach a functional prototype quickly.
Contact Perseus Biomics in Belgium
Contact us to explore licensing or partnership opportunities for rapid microbiome profiling.
